Advertisement

Jansen Jab Gets The EMA’s Go Ahead

The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the...

Share this article

09.41 21 Apr 2021


Jansen Jab Gets The EMA’s Go Ahead


Listen to this episode


Share this article

09.41 21 Apr 2021


The benefits of the Johnson & Johnson Covid-19 vaccine outweigh the risks - that’s what the European Medicines Agency concluded yesterday. Concerns about the Jansen jab’s safety had been raised following reports of a small number of blood clots in US recipients. Professor of Experimental Immunology at Trinity College Dublin, Kingston Mills joined us this morning.

Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.

   

Download, listen and subscribe on the Newstalk App.

  

You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.


Read more about

Breakfast Covid Vaccine Jansen Vaccine Johnson And Johnson Newstalk Newstalk Breakfast Vaccine

Related Episodes

Why Charlie Kirk’s Turning Poi...

00:26:04

Why Charlie Kirk’s Turning Point Is Targeting Irish Students

Newstalk Daily

00:26:04


This Land Is Your Land

00:48:16

This Land Is Your Land

Documentary On Newstalk

00:48:16


This Weekend's Sport

00:10:21

This Weekend's Sport

The Anton Savage Show

00:10:21


How to Quit Your Job

00:09:45

How to Quit Your Job

The Anton Savage Show

00:09:45